Stocks and Investing Stocks and Investing
Fri, October 29, 2021
[ 12:00 AM ] - WOPRAI
Daniel Kurnos Maintained (AMZN) at Strong Buy on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Jason Helfstein Maintained (AMZN) at Buy on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (AMZN) at Strong Buy on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Brian White Maintained (AMZN) at Strong Buy on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Maintained (AMZN) at Buy on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Brandon Nispel Maintained (AMT) at Buy with Increased Target to $311 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Sami Badri Maintained (AMT) at Buy with Increased Target to $328 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Kenneth Lee Maintained (AMP) at Buy with Increased Target to $350 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Kenneth Lee Maintained (ARES) at Buy with Increased Target to $98 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Yatin Suneja Upgraded (ARGX) to Strong Buy and Held Target at $330 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Naved Khan Initiated (ACVA) at Strong Buy and Held Target at $30 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Ramsey El-Assal Maintained (ADP) at Buy with Increased Target to $247 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (AJG) at Buy with Increased Target to $182 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Mark Dwelle Maintained (AJG) at Hold with Increased Target to $166 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Jamie Cook Maintained (AGCO) at Buy with Decreased Target to $155 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Allen Klee Upgraded (AGYS) to Strong Buy and Held Target at $65 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Quinn Bolton Maintained (ALGM) at Strong Buy with Increased Target to $40 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Blayne Curtis Maintained (ALGM) at Buy with Increased Target to $38 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
John Pitzer Maintained (ALGM) at Buy with Increased Target to $40 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Spak Upgraded (BC) to Buy and Held Target at $115 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (BC) at Buy with Decreased Target to $120 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Peter Levine Initiated (ZM) at Hold and Held Target at $255 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Tracy Benguigui Maintained (ACGL) at Buy with Increased Target to $50 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Mark Dwelle Maintained (ACGL) at Buy with Increased Target to $49 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Martin Yang Maintained (AAPL) at Buy with Increased Target to $170 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Tim Long Maintained (AAPL) at Hold with Increased Target to $145 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Decreased Target to $164 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Peter Levine Initiated (BILL) at Hold and Held Target at $300 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
Eric Beder Maintained (BWMX) at Strong Buy with Decreased Target to $45 on, Oct 29th, 2021
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (BPMC) at Hold with Increased Target to $111 on, Oct 29th, 2021

David Lebovitz Maintained (BPMC) at Hold with Increased Target to $111 on, Oct 29th, 2021


Published on 2024-10-27 18:25:00 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Increased Target from $96 to $111 on, Oct 29th, 2021.

David has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 28th, 2021
Contributing Sources